Incidence of Abcd1 level on the induction of cell death and organelle dysfunctions triggered by very long chain fatty acids and TNF-α on oligodendrocytes and astrocytes

NeuroToxicology

Volumn 33, Issue 2, 2012, Pages 212-228

  Baarine, Mauhamad ^a   Ragot, Kévin ^a   Athias, Anne ^b   Nury, Thomas ^a   Kattan, Zilal ^a   Genin, Emmanuelle C ^a   Andreoletti, Pierre ^a   Ménétrier, Franck ^c   Riedinger, Jean Marc ^d   Bardou, Marc ^e   Lizard, Gérard ^a  

^a Chu   (France)

^b HÔPITAL DU BOCAGE   (France)

^c CENTRE DES SCIENCES DU GOÛT ET DE L ALIMENTATION   (France)

^d Centre de Lutte Contre le Cancer GF Leclerc   (France)

^e DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

158N oligodendrocytes; C24:0; C26:0; C6 glioma cells; Cell death; Lysosome; Mitochondria; Peroxisome; Primary culture of glial cells; TNF ; Very long chain fatty acids

Indexed keywords

ABC TRANSPORTER; ACYL COENZYME A OXIDASE; ATP BINDING CASSETTE TRANSPORTER TYPE D1; ATP BINDING CASSETTE TRANSPORTER TYPE D3; HEXACOSANOIC ACID; LIGNOCERIC ACID; LONG CHAIN FATTY ACID; MEMBRANE PROTEIN; MYELIN; PROPIDIUM IODIDE; PROTEIN ACOX 1; SMALL INTERFERING RNA; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VERY LONG CHAIN FATTY ACID;

ADRENOLEUKODYSTROPHY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ATP BINDING CASSETTE TRANSPORTER TYPE D1 GENE; CELL DAMAGE; CELL GROWTH; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE; HUMAN; HUMAN CELL; LIPOGENESIS; LYSOSOME; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL TOXICITY; MOLECULAR STABILITY; MOUSE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROTOXICITY; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ADRENOLEUKODYSTROPHY; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; ATP-BINDING CASSETTE TRANSPORTERS; BRAIN; CATALASE; CELL SIZE; CELLS, CULTURED; CHEMOKINE CCL22; CHROMATOGRAPHY, GAS; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS; FEMALE; FLOW CYTOMETRY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; NEURONS; OLIGODENDROGLIA; ORGANELLES; RATS; RATS, WISTAR; RNA, MESSENGER; RNA, SMALL INTERFERING; STATISTICS, NONPARAMETRIC; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; RATTUS;

EID: 84858008091     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2011.10.007     Document Type: Article

References (80)

1. Aktas O., Schulze-Topphoff U., Zipp F. The role of TRAIL/TRAIL receptors in central nervous system pathology. Front Biosci 2007, 12:2912-2921.
2. Altmeyer A., Jung A.C., Ignat M., Benzina S., Denis J.M., Gueulette J., et al. Pharmacological enhancement of autophagy induced in a hepatocellular carcinoma cell line by high-LET radiation. Anticancer Res 2010, 30:303-310.
3. Arnauld S., Fidaleo M., Clémencet M.C., Chevillard G., Athias A., Gresti J., et al. Modulation of the hepatic fatty acid pool in peroxisomal 3-ketoacyl-CoA thiolase B-null mice exposed to the selective PPARalpha agonist Wy14,643. Biochimie 2009, 91:1376-1386.
4. Baarine M., Ragot K., Genin E.C., El Hajj H., Trompier D., Andreoletti P., et al. Peroxisomal and mitochondrial status of two murine oligodendrocytic cell lines (158N, 158JP): potential models for the study of peroxisomal disorders associated with dysmyelination processes. J Neurochem 2009, 111:119-131.
5. Baes M., Aubourg P. Peroxisomes, myelination, and axonal integrity in the CNS. Neuroscientist 2009, 15:367-379.
6. Baumann N., Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 2001, 81:871-927.
7. Baumgart E., Vanhorebeek I., Grabenbauer M., Borgers M., Declercq P.E., Fahimi H.D., et al. Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). Am J Pathol 2001, 159:1477-1494.
8. Benzina S., Altmeyer A., Malek F., Dufour P., Denis J.M., Gueulette J., et al. High-LET radiation combined with oxaliplatin induce autophagy in U-87 glioblastoma cells. Cancer Lett 2008, 264:63-70.
9. Berger J., Gärtner J. X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects. Biochim Biophys Acta 2006, 1763:1721-1732.
10. Bottelbergs A., Verheijden S., Hulshagen L., Gutmann D.H., Goebbels S., Nave K.A., et al. Axonal integrity in the absence of functional peroxisomes from projection neurons and astrocytes. Glia 2010, 58:1532-1543.
11. Boya P., Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene 2008, 27:6434-6451.
12. Deon M., Garcia M.P., Sitta A., Barschak A.G., Coelho D.M., Schimit G.O., et al. Hexacosanoic and docosanoic acids plasma levels in patients with cerebral childhood and asymptomatic X-linked adrenoleukodystrophy: Lorenzo's oil effect. Metab Brain Dis 2008, 23:43-49.
13. Dubois-Dalcq M., Feigenbaum V., Aubourg P. The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder. Trends Neurosci 1999, 22:4-12.
14. Eichler F., Van Haren K. Immune response in leukodystrophies. Pediatr Neurol 2007, 37:235-244.
15. Eichler F.S., Ren J.Q., Cossoy M., Rietsch A.M., Nagpal S., Moser A.B., et al. Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy?. Ann Neurol 2008, 63:729-742.
16. Feigenbaum V., Gélot A., Casanova P., Daumas-Duport C., Aubourg P., Dubois-Dalcq M. Apoptosis in the central nervous system of cerebral adrenoleukodystrophy patients. Neurobiol Dis 2000, 7(6 Pt B):600-612.
17. Ferrer I., Aubourg P., Pujol A. General aspects and neuropathology of X-linked adrenoleukodystrophy. Brain Pathol 2010, 20:817-830.
18. Feutz A.C., Pham-Dinh D., Allinquant B., Miehe M., Ghandour S. An immortalized Jimpy oligodendrocyte cell line: defects in cell cycle and cAMP pathway. Glia 2001, 34:241-252.
19. Folch J., Lees M., Sloanes Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 226:497-509.
20. Fouquet F., Zhou J.M., Ralston E., Murray K., Troalen F., Magal E., et al. Expression of the adrenoleukodystrophy protein in the human and mouse central nervous system. Neurobiol Dis 1997, 3:271-285.
21. Fourcade S., López-Erauskin J., Galino J., Duval C., Naudi A., Jove M., et al. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. Hum Mol Genet 2008, 17:1762-1773.
22. Fourcade S., Ruiz M., Guilera C., Hahnen E., Brichta L., Naudi A., et al. Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy. Hum Mol Genet 2010, 19:2005-2014.
23. Galino J., Ruiz M., Fourcade S., Schlüter A., López-Erauskin J., Guilera C., et al. Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy. Antioxid Redox Signal 2011, 15:2095-2107.
24. Gärtner J., Valle D. The 70kDa peroxisomal membrane protein: an ATP-binding cassette transporter protein involved in peroxisome biogenesis. Semin Cell Biol 1993, 4:45-52.
25. Genin E.C., Geillon F., Gondcaille C., Athias A., Gambert P., Trompier D., et al. Substrate specificity overlap and interaction between adrenoleukodystrophy protein (ALDP/ABCD1) and adrenoleukodystrophy-related protein (ALDRP/ABCD2). J Biol Chem 2011, 286:8075-8084.
26. Gondcaille C., Depreter M., Fourcade S., Lecca M.R., Leclercq S., Martin P.G., et al. Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator. J Cell Biol 2005, 169:93-104.
27. Guicciardi M.E., Leist M., Gores G.J. Lysosomes in cell death. Oncogene 2004, 23:2881-2890.
28. Hein S., Schönfeld P., Kahlert S., Reiser G. Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture. Hum Mol Genet 2008, 17:1750-1761.
29. Höftberger R., Kunze M., Weinhofer I., Aboul-Enein F., Voigtländer T., Oezen I., et al. Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: implications for X-linked adrenoleukodystrophy. Neurobiol Dis 2007, 28:165-174.
30. Hubbard W.C., Moser A.B., Liu A.C., Jones R.O., Steinberg S.J., Lorey F., et al. Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method. Mol Genet Metab 2009, 97:212-220.
31. Hudspeth M.P., Raymond G.V. Immunopathogenesis of adrenoleukodystrophy: current understanding. J Neuroimmunol 2007, 182:5-12.
32. Huin C., Schohn H., Hatier R., Bentejac M., Antunes L., Plénat F., et al. Expression of peroxisome proliferator-activated receptors alpha and gamma in differentiating human colon carcinoma Caco-2 cells. Biol Cell 2002, 94:15-27.
33. Ito M., Blumberg B.M., Mock D.J., Goodman A.D., Moser A.B., Moser H.W., et al. Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation. J Neuropathol Exp Neurol 2001, 60:1004-1019.
34. Kahn E., Baarine M., Dauphin A., Ragot K., Tissot N., Seguin A., et al. Characterization of lipid membrane organization revealed by LAURDAN color shift during cell death induced by 7-ketocholesterol and very long chain fatty acids on 158N murine oligodendrocytes: investigation by mono- and bi-photon spectral imaging confocal microscopy associated with Factor Analysis of Medical Image Sequences (FAMIS). Cytometry A 2011, 79A:293-305.
35. Kassmann C., Lappe-Siefke C., Baes M., Brügger B., Mildner A., Werner H.K., et al. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat Genet 2007, 39:969-976.
36. Kemp S., Pujol A., Waterham H.R., van Geel B.M., Boehm C.D., Raymond G.V., et al. ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Hum Mutat 2001, 18:499-515.
37. Kemp S., Wanders R.J. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment. Mol Genet Metab 2007, 90:268-276.
38. Kemp S., Wanders R. Biochemical aspects of X-linked adrenoleukodystrophy. Brain Pathol 2010, 20:831-837.
39. Khan M., Pahan K., Singh A.V., Singh I. Cytokin-induced accumulation of very long chain fatty acids in rat C6 glial cells: implication for X-adrenoleukodystrophy. J Neurochem 1998, 71:78-87.
40. Khan M., Singh J., Gilg A.G., Uto T., Singh I. Very long-chain fatty acid accumulation causes lipotoxic response via 5-lipoxygenase in cerebral adrenoleukodystrophy. J Lipid Res 2010, 51:1685-1695.
41. Kirkman H.N., Gaetani G.F. Mammalian catalase: a venerable enzyme with new mysteries. Trends Biochem Sci 2007, 32:44-50.
42. Kobayashi T., Shinnoh N., Kondo A., Yamada T. Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem Biophys Res Commun 1997, 232:631-636.
43. Kristensen A.R., Schandorff S., Høyer-Hansen M., Nielsen M.O., Jäättelä M., Dengjel J., et al. Ordered organelle degradation during starvation-induced autophagy. Mol Cell Proteomics 2008, 7:2419-2428.
44. Kroemer G., Petit P., Zamzami N., Vayssière J.L., Mignotte B. The biochemistry of programmed cell death. FASEB J 1995, 9:1277-1287.
45. Kroemer G., Jäättelä M. Lysosomes and autophagy in cell death control. Nat Rev Cancer 2005, 5:886-897.
46. Kroemer G., Galluzzi L., Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007, 87:99-163.
47. Lemaire-Ewing S., Prunet C., Montange T., Vejux A., Berthier A., Bessède G., et al. Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. Cell Biol Toxicol 2005, 21:97-114.
48. Lim M. Treating inflammation in childhood neurodegenerative disorders. Dev Med Child Neurol 2011, 53:298-304.
49. Lizard G., Fournel S., Genestier L., Dhedin N., Chaput C., Flacher M., et al. Kinetics of plasma membrane and mitochondrial alterations in cells undergoing apoptosis. Cytometry 1995, 21:275-283.
50. Lizard G., Gueldry S., Deckert V., Gambert P., Lagrost L. Evaluation of the cytotoxic effects of some oxysterols and of cholesterol on endothelial cell growth: methodological aspects. Pathol Biol (Paris) 1997, 45:281-290.
51. Lorz C., Mehmet H. The role of death receptors in neural injury. Front Biosci 2009, 14:583-595.
52. McCarthy K.D., de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 1980, 85:890-902.
53. Manjithaya R., Nazarko T.Y., Farré J.C., Subramani S. Molecular mechanism and physiological role of pexophagy. FEBS Lett 2010, 584:1367-1373.
54. Mosser J., Douar A.M., Sarde C.O., Kioschis P., Feil R., Moser H., et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993, 361:726-730.
55. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
56. Oaxaca-Castillo D., Andreoletti P., Vluggens A., Yu S., van Veldhoven P.P., Reddy J.K., et al. Biochemical characterization of two functional human liver acyl-CoA oxidase isoforms 1a and 1b encoded by a single gene. Biochem Biophys Res Commun 2007, 360:314-319.
57. Oezen I., Rossmanith W., Forss-Petter S., Kemp S., Voigtländer T., Moser-Thier K., et al. Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiency. Hum Mol Genet 2005, 14:1127-1137.
58. Olsson M., Rundquist I., Brunk U. Flow cytofluorometry of lysosomal acridine orange uptake by living cultured cells. Acta Pathol Microbiol Immunol Scand A 1987, 95:159-165.
59. Paintlia A.S., Gilg A.G., Khan M., Singh A.K., Barbosa E., Singh I. Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies. Neurobiol Dis 2003, 14:425-439.
60. Paintlia A.S., Paintlia M.K., Singh A.K., Orak J.K., Singh I. Activation of PPAR-γ and PTEN cascade participates in lovastatin-mediated accelerated differentiation of oligodendrocyte progenitor cells. Glia 2010, 58:1669-1685.
61. Pohl J., Ring A., Ehehalt R., Herrmann T., Stremmel W. New concepts of cellular fatty acid uptake: role of fatty acid transport proteins and of caveolae. Proc Nutr Soc 2004, 63:259-262.
62. Powers J.M., Liu Y., Moser A.B., Moser H.W. The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications. J Neuropathol Exp Neurol 1992, 51:630-643.
63. Powers J.M., Pei Z., Heinzer A.K., Deering R., Moser A.B., Moser H.W., et al. Adreno-leukodystrophy: oxidative stress of mice and men. J Neuropathol Exp Neurol 2005, 64:1067-1079.
64. Prunet C., Montange T., Véjux A., Laubriet A., Rohmer J.F., Riedinger J.M., et al. Multiplexed flow cytometric analyses of pro- and anti-inflammatory cytokines in the culture media of oxysterol-treated human monocytic cells and in the sera of atherosclerotic patients. Cytometry A 2006, 69:359-373.
65. Robinson K.M., Janes M.S., Beckman J.S. The selective detection of mitochondrial superoxide by live cell imaging. Nat Protoc 2008, 3:941-947.
66. Schrader M., Fahimi H.D. Mammalian peroxisomes and reactive oxygen species. Histochem Cell Biol 2004, 122:383-393.
67. Shao Y., Gao Z., Marks P.A., Jiang X. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci USA 2004, 101. 18030-.
68. Singh I., Kishimoto Y. Effect of cyclodextrins on the solubilization of lignoceric acid, ceramide, and cerebroside, and on the enzymatic reactions involving these compounds. J Lipid Res 1983, 24:662-665.
69. Singh I., Pujol A. Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis. Brain Pathol 2010, 20:838-844.
70. Schumann U., Subramani S. Special delivery from mitochondria to peroxisomes. Trends Cell Biol 2008, 18:253-256.
71. Takemoto Y., Suzuki Y., Horibe R., Shimozawa N., Wanders R.J., Kondo N. Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders. Brain Dev 2003, 25:481-487.
72. Titorenko V.I., Terlecky S.R. Peroxisome metabolism and cellular aging. Traffic 2011, 12:252-259.
73. Valianpour F., Selhorst J.J., van Lint L.E., van Gennip A.H., Wanders R.J., Kemp S. Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry. Mol Genet Metab 2003, 79:189-196.
74. Vluggens A., Andreoletti P., Viswakarma N., Jia Y., Matsumoto K., Kulik W., et al. Reversal of mouse Acyl-CoA oxidase 1 (ACOX1) null phenotype by human ACOX1b isoform. Lab Invest 2010, 90:696-708.
75. Wanders R.J. Peroxisomes, lipid metabolism, and peroxisomal disorders. Mol Genet Metab 2004, 83:16-27.
76. Wanders R.J., Ferdinandusse S., Brites P., Kemp S. Peroxisomes, lipid metabolism and lipotoxicity. Biochim Biophys Acta 2010, 1801:272-280.
77. Wanders R.J., Waterham H.R. Biochemistry of mammalian peroxisomes revisited. Annu Rev Biochem 2006, 75:295-332.
78. Wilhelm I., Fazakas C., Krizbai I.A. In vitro models of the blood-brain barrier. Acta Neurobiol Exp (Wars) 2011, 71:113-128.
79. Yamashima T., Oikawa S. The role of lysosomal rupture in neuronal death. Prog Neurobiol 2009, 89:343-358.
80. Yuan X.M., Li W., Brunk U.T., Dalen H., Chang Y.H., Sevanian A. Lysosomal destabilization during macrophage damage induced by cholesterol oxidation products. Free Radic Biol Med 2000, 28:208-218.